Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 92 for “"CYP2C9"”.

  1. Factors affecting CYP2C9-mediated metabolism

    … kinetics. In particular, dapsone activates CYP2C9-mediated flurbiprofen 4 '-hydroxylation. However, the mechanism of activation of CYP2C9 is poorly understood. The activation of flurbiprofen, naproxen, and piroxicam metabolism by dapsone was investigated, fitting kinetic data to a two-site …

    wvu Repository record for Factors affecting CYP2C9-mediated metabolism (opens in a new tab)

  2. Dapsone activation of CYP2C9 allelic variants

    Studies have shown that CYP2C9.1 mediated metabolism of flurbiprofen and naproxen is activated by dapsone. However, dapsone activation has not been studied in the allelic variant forms of CYP2C9. Six concentrations of flurbiprofen or naproxen were co-incubated with six concentrations of dapsone and …

    wvu Repository record for Dapsone activation of CYP2C9 allelic variants (opens in a new tab)

  3. Genetisch bedingte Unterschiede der CYP2C9-Aktivität: Einfluss von Enzyminduktion

    … ist als Probesubstrat zur Bestimmung der CYP2C9-Aktivität in vivo validiert. Die Wirkung von Rifampicin als CYP2C9 Enzym-Induktor ist in zahlreichen Studien belegt. Vorliegende Studie untersucht die Aktivität von CYP2C9-Polymorphismen mit Tolbutamid als Probesubstrat vor und nach Induktion …

    fu-berlin Repository record for Genetisch bedingte Unterschiede der CYP2C9-Aktivität: Einfluss von Enzyminduktion (opens in a new tab)

  4. The Impact of R10-Hydroxywarfarin on CYP2C9-Mediated S-Warfarin Metabolism

    … inherited variants of the Cytochrome P450 2C9 (CYP2C9) isoform. This enzyme is critical for the elimination of the more potent S–enantiomer of warfarin. Another 24–30% can be attributable to different variants of the gene <italic>VKORC1 </italic>, which codes for the target enzyme that warfarin …

    washington Repository record for The Impact of R10-Hydroxywarfarin on CYP2C9-Mediated S-Warfarin Metabolism (opens in a new tab)

  5. Computer modeling of dapsone-mediated heteroactivation of flurbiprofen metabolism by CYP2C9

    … heteroactivation of flurbiprofen metabolism by CYP2C9 has been developed for the purpose of elucidating key interactions between substrate, effector, and enzyme responsible for heteroactivation in this system, as well as to predict as yet unknown activators.

    wvu Repository record for Computer modeling of dapsone-mediated heteroactivation of flurbiprofen metabolism by CYP2C9 (opens in a new tab)

  6. Meta-analysis of the population and phenotypic expression of CYP2C9/2C19 polymorphism on drug metabolism in different ethnicities

    … studies. In this thesis, the prevalence of CYP2C9/2C19 alleles between different ethnicities has been estimated through meta-analysis and the population genetic principle. The clinical outcome of CYP2C9/2C19 allelic variation on the pharmacotherapy of epilepsy has been investigated; although …

    aston Download PDF for Meta-analysis of the population and phenotypic expression of CYP2C9/2C19 polymorphism on drug metabolism in different ethnicities (opens in a new tab)

  7. Frecuencias alélicas y genotípicas de polimorfismos en los genes cyp2c9, vkorc1 y cyp4f2 en pacientes colombianos anticoagulados con warfarina

    The oral anticoagulant warfarin is the most used worldwide, formulated for the treatment and prevention of thrombotic diseases, its narrow therapeutic index and the wide variability between patients make it difficult dosage, so it is necessary to determine the frequencies of polymorphisms in genes …

    rosario Repository record for Frecuencias alélicas y genotípicas de polimorfismos en los genes cyp2c9, vkorc1 y cyp4f2 en pacientes colombianos anticoagulados con warfarina (opens in a new tab)

  8. Μελέτη των πολυμορφισμών του κυτοχρώματος P450 και η επίδραση τους στη θεραπεία με αντιβιταμίνες K σε έλληνες ασθενείς

    Acenocoumarol is mainly catabolized by CYP2C9 isoform of cytochrome P450 (CYP) liver complex and exerts its anticoagulant effect through the inhibition of Vitamin K Epoxide Reductase (VKOR). The most important genetic polymorphisms which lead to an impaired enzymatic activity and therefore …

    greece Repository record for Μελέτη των πολυμορφισμών του κυτοχρώματος P450 και η επίδραση τους στη θεραπεία με αντιβιταμίνες K σε έλληνες ασθενείς (opens in a new tab)

  9. Use of protein immobilization to measure cytochrome P450 conduction and metabolism kinetics

    … between three key drug-metabolizing isoforms (CYP2C9, CYP3A4, and CYP2D6). Molecular modeling was used to assess the favorability of homo/heteromeric P450 complex formation. P450 complex formation in vitro was analyzed in real-time utilizing surface plasmon resonance (SPR). Lastly, the effects …

    wvu Repository record for Use of protein immobilization to measure cytochrome P450 conduction and metabolism kinetics (opens in a new tab)

  10. Pharmacometric analyses of drug exposure and response data

    … vivo inhibition constant (Ki) across different CYP2C9 genotypes. In the second project, a model-based meta-analysis was performed to describe the time-course of virologic response in hepatitis C clinical trials across current approved treatments. The inhibition constant (Ki) of an inhibitor is …

    umn Repository record for Pharmacometric analyses of drug exposure and response data (opens in a new tab)

  11. Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P4502C9 für die Pharmakokinetik des Antikoagulanz Phenprocoumon

    CYP2C9 katalysiert die Biotransforamtion der oralen Antikoagulantien S-Warfarin, S- und R-Acenocoumarol. Wie bereits in in vitro Studien festgestellt wurde, wird auch der Vitamin K-Antagonist Phenprocoumon über CYP2C9 metabolisiert. Jedoch gibt es bisher noch keine sicheren in vivo Studien, die den …

    fu-berlin Repository record for Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P4502C9 für die Pharmakokinetik des Antikoagulanz Phenprocoumon (opens in a new tab)

  12. Investigation of individual differences in the metabolic elimination of drugs by the polymorphic enzymes CYP2C9, 2C19 and 2D6 based on metabolite profiling by LC-MS/MS

    … der drei zuvor erwähnten CYPs (CYP2D6, CYP2C9 und CYP2C19) entwickelt, und zum anderen die Vorhersagekraft des Genotyps für den gemessenen Phänotyp näher untersucht werden sollte. Es ist uns gelungen eine sichere, einfache, schnelle und kombinierte Phänotypisierung der beiden wichtigen …

    wurz-thes Repository record for Investigation of individual differences in the metabolic elimination of drugs by the polymorphic enzymes CYP2C9, 2C19 and 2D6 based on metabolite profiling by LC-MS/MS (opens in a new tab)

  13. The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype

    … liver microsomes (HLM) from donors with the CYP2C9*1/*1 genotype were incubated with VPA and GBE, and the formation of 4-ene-VPA, 4-OH-VPA, 5-OH-VPA, and 3-OH-VPA were monitored by GC/MS in NICI mode. GBE inhibited the formation of all four metabolites in a dose-dependent manner. GBE from …

    ubc Repository record for The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype (opens in a new tab) Download PDF for The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype (opens in a new tab)

  14. Analytical and Computational Methods for the Assessment of Biological Molecules and their Binding Interactions: Case Studies in DNA Aptamer-Target Binding and P450-P450 Dimerization

    … docking web server. Binding poses for CYP2C9 with enzyme partners CYP2C9, CYP2D6, CYP3A4, and CPR preferentially involved the CYP2C9 surface where the solvent entrance tunnel is located, which were identified using STAMP structural alignment. Binding affinity data derived from surface …

    wvu Repository record for Analytical and Computational Methods for the Assessment of Biological Molecules and their Binding Interactions: Case Studies in DNA Aptamer-Target Binding and P450-P450 Dimerization (opens in a new tab)

  15. Immobilized Cytochrome P450 2C9 (CYP2C9): Applications for Metabolite Generation, Monitoring Protein-Protein Interactions, and Improving In-vivo Predictions Using Enhanced In-vitro Models

    Cytochrome P450 (P450) enzymes are a family of oxoferroreductase enzymes containing a heme moiety and are well known to be involved in the metabolism of a wide variety of endogenous and xenobiotic materials. It is estimated that roughly 75% of all pharmaceutical compounds are metabolized by these …

    wvu Repository record for Immobilized Cytochrome P450 2C9 (CYP2C9): Applications for Metabolite Generation, Monitoring Protein-Protein Interactions, and Improving In-vivo Predictions Using Enhanced In-vitro Models (opens in a new tab)

  16. Farmacogenética da varfarina : proposta de um algoritmo para a predição de dose

    … com fatores ambientais e genéticos. As enzimas CYP2C9, responsável pela maior parte da metabolização do fármaco, e VKORC1, alvo dos cumarínicos, estão diretamente envolvidas na farmacocinética e farmacodinâmica da varfarina, respectivamente. A enzima CYP4F2, envolvida na metabolização de …

    brazil-ufrgs Repository record for Farmacogenética da varfarina : proposta de um algoritmo para a predição de dose (opens in a new tab)

  17. The pharmacogenomics of warfarin safety and effectiveness in children

    … reactions (ADRs). Polymorphisms in two genes , CYP2C9 and VK ORC1 , have consistently been shown to be associated with warfar in dose requirements in adults. However, evidence on the importance of genetics in warfarin therapy in children is limited. Further paediatric studies are required to …

    ubc Repository record for The pharmacogenomics of warfarin safety and effectiveness in children (opens in a new tab) Download PDF for The pharmacogenomics of warfarin safety and effectiveness in children (opens in a new tab)

  18. High-throughput methods of studying human cytochrome P450 activity in Saccharomyces cerevisiae

    … to a particularly important pharmacogene: CYP2C9, genetic variation in which affects the efficacy of warfarin, phenytoin, and other drugs. We coupled our yeast activity assay with fluorescence-activated cell sorting and high throughput sequencing, and generated activity scores for 6,142 …

    washington Repository record for High-throughput methods of studying human cytochrome P450 activity in Saccharomyces cerevisiae (opens in a new tab)

Page 1 of 5